Menu

Close

Disrupting Transcriptional Feedback Yields an Escape-Resistant Antiviral

Sonali Chaturvedi, Marie Wolf, Noam Vardi, Matilda Chan, Leor Weinberger

Preprint posted on November 26, 2018 https://www.biorxiv.org/content/early/2018/11/26/464495

Dr. Weinberger and colleagues create a new anti-viral drug modality that uses a 28 base pair piece of DNA to have the virus reduce its own progression without any sign of resistance.

Selected by Pavithran Ravindran

Background

From cancers to viruses, treatment of diseases is hindered by the emergence of resistance. Resistance is typically thought to arise by mutations in the protein that a drug is targeting. Diseases such as cancer and viruses have very high mutation rates and thus resistance tends to crop up quite quickly. Therefore, scientists have tried to utilize combination drug protocols that target multiple nodes in a particular disease development (e.g. the reverse transcriptase and integrase of a virus). There are two problems with such a method: (a) there must be two distinct drug targets available and (b) the drugs for both targets need to have compatible bioavailability, kinetics, efficacy, toxicity, etc. This scheme has been proving effective, but still does not seem to work, for resistance still occurs. The authors of this work wanted to find a new modality by which viral infections could be targeted and, ideally, cured without resistance.

Key Findings

One target that has not been exploited as of yet is auto-regulatory circuits that are present in viruses, specifically in herpes simplex virus type one (HSV-1) and cytomegalovirus (CMV). In normal viral progression, proteins such as IE86 in CMV and IE175 in HSV-1 are very closely regulated by negatively feeding back on their own promoters. However, if this circuit were to be broken, these proteins would build up in large amounts, kill the host cell, and ultimately decrease viral progression. The authors of this study chose to make a new type of oligonucleotide “drug” that would mimic the domain of the promoter that these IE proteins bind to, titrate away the IE proteins from the promoter they should be acting on and thus deregulate the amount of this cytotoxic protein that is made. They called this new drug modality circuit disruptor oligonucleotide therapy (C-DOTs). With this, infected cells would die and reduce the viral progression (Figure 1).

Figure 1. Figure 1A from original preprint. Schematic describing C-DOT therapeutic strategy; when cells are infected with a virus and IE proteins are able to negatively feedback on their promoter, normal viral production occurs but when C-DOTs occupy IE protein binding sites and then too much cytotoxic IE protein is made, the infected cell dies and viral progression is reduced.

 

The authors first had to find an oligonucleotide sequence that could bind the IE proteins and titrate them away from their natural binding partner. For this, they developed a liquid chromatography based assay that could detect IE protein, DNA and the complex of the two together. With this assay they determined that the optimal oligonucleotide size is 28 base pairs. They further validated some of their hits using a GFP attached to the IE86 protein that was driven by the promoter for IE86 that should be shut down once some IE86 is made. When these cells were treated with the 28 base pair oligonucleotide matching the cis-regulatory sequence in the promoter, there was a significant increase in GFP positive cells.

To evaluate C-DOTS for anti-viral activity, the authors took the C-DOT against CMV (C-DOTC) and against HSV-1 (C-DOTH) and treated cells that were infected with the corresponding virus. The authors were able to find something especially interesting – at low multiplicity of infection (MOI) the C-DOT treatment worked as well as the conventional therapy but at higher MOI the C-DOTs worked better. This is not surprising when one considers the fact that the C-DOT therapy takes advantage of increased amounts of the IE proteins that should be regulated closely; in the case of the higher MOI, there are more viral genomes per cell and thus, more opportunities to have increased amount of IE protein to cause cell death and decreased viral load. Amazingly, the authors found that this treatment could be used for a wide range of viral strains, not just the one that they were using to characterize the treatment in the first place.

 Figure 2. Figure 3E-G from original preprint. Cells were infected with CMV or HSV and C-DOT therapy was compared to current therapeutic strategies. In both cases, resistance occurred very quickly after current therapy was used while the C-DOT was effective in keeping viral load low and almost undetectable.

 

The biggest concern that the authors were trying to combat was resistance. To test if the C-DOT therapy could do better than conventional therapies (Fomivirsen for CMV and ACV for HSV-1) in terms of resistance strains forming, the authors performed an assay in which the virus was continuously passaged from infected cells to non-infected cells every four days and the virus was tittered during each passaging. They found that the conventional therapies produced resistance within 12 days while the C-DOT therapy amazingly had essentially zero resistance form for up to 40 days in culturing cells, with CMV titers staying below the limit of detection at day 52 (Figure 2). The authors were even able to take this to the next level by implementing their treatment in mice. When C-DOTs were given to mice challenged with the corresponding virus, the authors saw amazing reduction in viral loads (150 fold decrease in the case of HSV-1).

Why I chose this preprint

The simplicity yet brilliance of the work described here is the major reason why I chose this particular preprint- the idea that one can use the viruses’ own regulatory networks to get it to kill itself. This was simply done by titrating away the DNA binding protein using small oligonucleotides. Not only does this work provide a very promising therapy for CMV and HSV-1 described here, but it also provides a new therapeutic modality to test for other diseases such as cancer. A lot of work has been done showing how cancers rewire regulatory networks and so being able to take advantage of that would be an amazing achievement [1-2]. Furthermore, the readability of this particular work made it an especially fun reading experience – the language was concise and the figures were very clear with panels explaining hypothesized results.

Outstanding Questions

  1. What is the difference between Fomivirsen and the newer C-DOTC? How does the resistance arise for Fomivirsen and does this mechanism apply to C-DOTC?
  2. Is there a way that the binding of the C-DOT and IE protein can be compared to the endogenous promoter? If so, is there a way to increase the C-DOT binding to IE protein such that it is more preferential compared to the endogenous location?
  3. The idea that such feedback loops can be targeted for not just viruses but also other diseases such as cancers is very attractive. However, one of my questions is how one can identify targetable feedback loops?

References

  1. Fish L, Zhang S, Yu JX, et al. Cancer cells exploit an orphan RNA to drive metastatic progression. Nat Med. 2018;24(11):1743-1751.
  2. Bugaj LJ, Sabnis AJ, Mitchell A, et al. Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway. Science. 2018;361(6405).

Tags: feedback loops, viral

Posted on: 3rd January 2019

Read preprint (No Ratings Yet)




  • Author's response

    Leor Weinberger shared

    To address your questions:

    Fomivirsen was an antisense oligonucleotide that blocked translation of the IE2 mRNA by binding to the complementary sequence of the IE2 mRNA. Fomivirsen was the first antisense antiviral approved by the FDA.  C-DOTs are essentially the exact opposite of antisense oligonucleotides; whereas antisense oligos knockdown expression of a target protein, C-DOTs increase the expression of the target protein to toxic levels.
    It is still not perfectly clear how resistance to Fomivirsen arises, but the CMV mutations appear to be in sites that are distinct and removed from the complimentary region in the mRNA—which is consistent with the expression level or half-life of the mRNA being altered by the virus to compensate for the knockdown by fomivirsen.  This sort of up regulation of the mRNA is thought to be a common mechanism that cells can use to counter the effects of inhibition.  Since the C-DOT increases rather than decreases mRNA levels, you could think that a compensatory escape mechanism would be for the virus to generate mutations that reduced the mRNA lifetime (for example reducing the promoter strength).  However, we have shown previously (Teng et al. Cell 2012) that such mutations that reduce IE2 levels confer a severe fitness disadvantage for the virus because the rate of accumulation of IE2 is necessarily much slower.  This is why we think that the mutations don’t arise; they don’t have a strong selective advantage.

    Regarding your question about increasing C-DOT binding efficiency relative to the native promoter this is a great question and something that we are actively working on.  The simplest approaches, such as screening for sequences that have higher binding affinity to IE2, don’t seem to work.  We believe this makes some evolutionary sense since the virus likely evolved the optimal binding sequences so finding a better one is unlikely, but we have other ideas. Stay tuned.

    Finally, regarding your question of identifying targetable feedback loops,  this is another great question.  There are some high-throughput approaches to identify feedback loops that are under development.  One involves identifying DNA-protein interactions and then focusing on those that are self-regulating.  This is actually a major goal of our work and a long-standing goal in the field of systems biology.

    Leor

    Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the biochemistry category:

    HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly

    C. Favard, J. Chojnacki, P. Merida, et al.



    Selected by Amberley Stephens

    Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry

    Stephanie Cara Bishop, Robert Winefield, Asokan Anbanandam, et al.



    Selected by Zhang-He Goh

    Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity

    Marion Regnier, Arnaud Polizzi, Sarra Smati, et al.



    Selected by Pablo Ranea Robles

    Microfluidic protein isolation and sample preparation for high resolution cryo-EM

    Claudio Schmidli, Stefan Albiez, Luca Rima, et al.



    Selected by David Wright

    ENDOSOMAL MEMBRANE TENSION CONTROLS ESCRT-III-DEPENDENT INTRA-LUMENAL VESICLE FORMATION

    Vincent Mercier, Jorge Larios, Guillaume Molinard, et al.



    Selected by Nicola Stevenson

    1

    Dynamic Aha1 Co-Chaperone Binding to Human Hsp90

    Javier Oroz, Laura J Blair, Markus Zweckstetter



    Selected by Reid Alderson

    1

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.



    Selected by Robert Mahen

    1

    Structures of the Otopetrin Proton Channels Otop1 and Otop3

    Kei Saotome, Bochuan Teng, Che Chun (Alex) Tsui, et al.



    Selected by David Wright

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    S-acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate desmosome assembly and cell adhesion.

    Keith T Woodley, Mark O Collins



    Selected by Abagael Lasseigne

    3

    A complex containing lysine-acetylated actin inhibits the formin INF2

    Mu A, Tak Shun Fung, Arminja N. Kettenbach, et al.



    Selected by Laura McCormick

    1

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates

    Applications, Promises, and Pitfalls of Deep Learning for Fluorescence Image Reconstruction

    Chinmay Belthangady , Loic A. Royer



    Selected by Romain F. Laine

    Activation of intracellular transport by relieving KIF1C autoinhibition

    Nida Siddiqui, Alice Bachmann, Alexander J Zwetsloot, et al.



    Selected by Ben Craske, Thibault Legal and Toni McHugh

    1

    Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis

    Jonathan P Gumucio, Austin H Qasawa, Patrick J Ferrara, et al.



    Selected by Pablo Ranea Robles

    Also in the microbiology category:

    Evolution-guided design of super-restrictor antiviral proteins reveals a breadth-versus-specificity tradeoff

    Rossana S Colon-Thillet, Emily S Hsieh, Laura Graf, et al.



    Selected by Connor Rosen

    HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly

    C. Favard, J. Chojnacki, P. Merida, et al.



    Selected by Amberley Stephens

    Synthetic pluripotent bacterial stem cells

    Sara Molinari, David L. Shis, James Chappell, et al.



    Selected by Lorenzo Lafranchi

    Short-range interactions govern cellular dynamics in microbial multi-genotype systems

    Alma Dal Co, Simon van Vliet, Daniel Johannes Kiviet, et al.

    AND

    Rapid microbial interaction network inference in microfluidic droplets

    Ryan H Hsu, Ryan L Clark, Jin Wei Tan, et al.



    Selected by Connor Rosen

    Bacteriophage resistance alters antibiotic mediated intestinal expansion of enterococci

    Anushila Chatterjee, Cydney N Johnson, Phat Luong, et al.



    Selected by Yasmin Lau

    Large-scale analyses of human microbiomes reveal thousands of small, novel genes and their predicted functions

    Hila Sberro, Nicholas Greenfield, Georgios Pavlopoulos, et al.



    Selected by Ganesh Kadamur

    Applications, Promises, and Pitfalls of Deep Learning for Fluorescence Image Reconstruction

    Chinmay Belthangady , Loic A. Royer



    Selected by Romain F. Laine

    Disrupting Transcriptional Feedback Yields an Escape-Resistant Antiviral

    Sonali Chaturvedi, Marie Wolf, Noam Vardi, et al.



    Selected by Pavithran Ravindran

    1

    Development and validation of serological markers for detecting recent exposure to Plasmodium vivax infection

    Rhea Jessica Longley, Michael T White, Eizo Takashima, et al.

    AND

    Antimalarial drug mefloquine kills both trophozoite and cyst stages of Entamoeba

    Conall Sauvey, Gretchen Ehrenkaufer, Anjan Debnath, et al.



    Selected by Zhang-He Goh

    Structure of a cytochrome-based bacterial nanowire

    David J Filman, Stephen F Marino, Joy E Ward, et al.



    Selected by Amberley Stephens

    Biofilm/Persister/Stationary Phase Bacteria Cause More Severe Disease Than Log Phase Bacteria II Infection with Persister Forms of Staphylococcus aureus Causes a Chronic Persistent Skin Infection with More Severe Lesion that Takes Longer to Heal and is not Eradicated by the Current Recommended Treatment in Mice

    Rebecca Yee, Yuting Yuan, Cory Brayton, et al.



    Selected by Snehal Kadam

    Acquired interbacterial defense systems protect against interspecies antagonism in the human gut microbiome

    Benjamin D. Ross, Adrian J. Verster, Matthew C. Radey, et al.



    Selected by Connor Rosen

    The Toll pathway inhibits tissue growth and regulates cell fitness in an infection-dependent manner

    Federico Germani, Daniel Hain, Denise Sternlicht, et al.



    Selected by Rohan Khadilkar

    The microbial basis of impaired wound healing: differential roles for pathogens, "bystanders", and strain-level diversification in clinical outcomes

    Lindsay Kalan, Jacquelyn S Meisel, Michael A Loesche, et al.



    Selected by Snehal Kadam

    CRISPR/Cas9-mediated gene deletion of the ompA gene in an Enterobacter gut symbiont impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes

    Shivanand Hegde, Pornjarim Nilyanimit, Elena Kozlova, et al.



    Selected by Snehal Kadam

    Agrobacterium tumefaciens divisome proteins regulate the transition from polar growth to cell division

    Matthew L Howell, Alena Aliashkevich, Kousik Sundararajan, et al.



    Selected by Hannah Behrens

    Also in the molecular biology category:

    Optical determination of absolute membrane potential

    Julia R. Lazzari-Dean, Anneliese M.M. Gest, Evan Miller



    Selected by James Marchant

    MicroRNA-mediated control of developmental lymphangiogenesis

    Hyun Min Jung, Ciara Hu, Alexandra M Fister, et al.



    Selected by Rudra Nayan Das

    Microfluidic protein isolation and sample preparation for high resolution cryo-EM

    Claudio Schmidli, Stefan Albiez, Luca Rima, et al.



    Selected by David Wright

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.



    Selected by Robert Mahen

    1

    Structures of the Otopetrin Proton Channels Otop1 and Otop3

    Kei Saotome, Bochuan Teng, Che Chun (Alex) Tsui, et al.



    Selected by David Wright

    Central spindle microtubules are strongly coupled to chromosomes during both anaphase A and anaphase B

    Che-Hang Yu, Stefanie Redemann, Hai-Yin Wu, et al.



    Selected by Federico Pelisch

    1

    Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division

    Evgeny Zatulovskiy, Daniel F. Berenson, Benjamin R. Topacio, et al.



    Selected by Zaki Ahmad

    1

    Distinct ROPGEFs successively drive polarization and outgrowth of root hairs

    Philipp Denninger, Anna Reichelt, Vanessa Aphaia Fiona Schmidt, et al.



    Selected by Marc Somssich

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    Bacteriophage resistance alters antibiotic mediated intestinal expansion of enterococci

    Anushila Chatterjee, Cydney N Johnson, Phat Luong, et al.



    Selected by Yasmin Lau

    On-site ribosome remodeling by locally synthesized ribosomal proteins in axons

    Toshiaki Shigeoka, Max Koppers, Hovy Ho-Wai Wong, et al.



    Selected by Srivats Venkataramanan

    MRE11-RAD50-NBS1 activates Fanconi Anemia R-loop suppression at transcription-replication conflicts

    Emily Yun-Chia Chang, James P Wells, Shu-Huei Tsai, et al.



    Selected by Katie Weiner

    1

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates

    Unlimited genetic switches for cell-type specific manipulation

    Jorge Garcia-Marques, Ching-Po Yang, Isabel Espinosa-Medina, et al.



    Selected by Rafael Almeida

    1

    Stable knockout and complementation of receptor expression using in vitro cell line derived reticulocytes for dissection of host malaria invasion requirements

    Timothy J Satchwell, Katherine E Wright, Katy L Haydn-Smith, et al.



    Selected by Alyson Smith
    Close